These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1085509)

  • 41. Reevaluation of the role of de novo protein synthesis in rat thymocyte apoptosis.
    Chow SC; Peters I; Orrenius S
    Exp Cell Res; 1995 Jan; 216(1):149-59. PubMed ID: 7813615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Podocin is translocated to cytoplasm in puromycin aminonucleoside nephrosis rats and in poor-prognosis patients with IgA nephropathy.
    Fukuda H; Hidaka T; Takagi-Akiba M; Ichimura K; Oliva Trejo JA; Sasaki Y; Wang J; Sakai T; Asanuma K; Tomino Y
    Cell Tissue Res; 2015 May; 360(2):391-400. PubMed ID: 25676004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myelotoxicity, nephrotoxicity, and erythropoietic stimulating factor production in animals treated with the aminonucleoside of puromycin.
    LANGE RD; GALLAGHER NI; McCARTHY JM; WRIGHT S
    J Lab Clin Med; 1959 Jun; 53(6):912-20. PubMed ID: 13665136
    [No Abstract]   [Full Text] [Related]  

  • 44. Puromycin aminonucleoside nephropathy: ultrastructure, glomerular polyanion, and cell surface markers.
    Rossmann P; Bukovský A; Matousovic K; Holub M; Král J
    J Pathol; 1986 Apr; 148(4):337-48. PubMed ID: 3517267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of puromycin on tyrosine hydroxylase activation in the vas deferens following nerve stimulation.
    Lee FL; Weiner N
    Proc West Pharmacol Soc; 1978; 21():203-8. PubMed ID: 29304
    [No Abstract]   [Full Text] [Related]  

  • 46. Delayed growth inhibition of human leukaemic cells in culture following treatment with aminonucleoside of puromycin.
    Novak JF; McMaster JH
    Cytobios; 1981; 30(117):49-59. PubMed ID: 6940692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aminonucleoside nephrosis. I. Electron microscopic study of the renal lesion in rats.
    VERNIER RL; PAPERMASTER BW; GOOD RA
    J Exp Med; 1959 Jan; 109(1):115-26. PubMed ID: 13611168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cordycepin (3'-deoxyadenosine) and pentostatin (deoxycoformycin) against Trypanosoma cruzi.
    do Carmo GM; de Sá MF; Grando TH; Gressler LT; Baldissera MD; Monteiro SG; Henker LC; Mendes RE; Stefani LM; Da Silva AS
    Exp Parasitol; 2019 Apr; 199():47-51. PubMed ID: 30825499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The neuroprotective effects of cordycepin inhibit glutamate-induced oxidative and ER stress-associated apoptosis in hippocampal HT22 cells.
    Jin ML; Park SY; Kim YH; Oh JI; Lee SJ; Park G
    Neurotoxicology; 2014 Mar; 41():102-11. PubMed ID: 24486958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lead-positive nuclear structures and their behavior under the effect of various drugs.
    Recher L; Parry N; Whitescarver J; Briggs L
    J Ultrastruct Res; 1972 Feb; 38(3):398-410. PubMed ID: 4110410
    [No Abstract]   [Full Text] [Related]  

  • 51. The effects of aminonucleoside of puromycin and nephrotoxic serum on subepithelial immune-deposit formation in passive Heymann nephritis.
    Couser WG; Salant DJ; Stilmant MM; Arbeit LA; Darby C; Sliogeris VG
    J Lab Clin Med; 1979 Dec; 94(6):917-32. PubMed ID: 501213
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of puromycin aminonucleoside on HSPG core protein content of glomerular epithelial cells.
    Kasinath BS; Singh AK; Kanwar YS; Lewis EJ
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F590-6. PubMed ID: 2972214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Podocytes in aminonucleoside glomerulonephritis investigated ultrastructurally with concanavalin A.
    Bretton R; Rouchon M; Bariety J
    J Histochem Cytochem; 1979 Dec; 27(12):1588-95. PubMed ID: 521617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD; Bertram JF; Ryan GB
    Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blockade of immune tolerance induction by puromycin aminonucleoside.
    Maserang DL; Hyde RM
    Cell Immunol; 1977 Jun; 31(2):255-65. PubMed ID: 326423
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of aminonucleoside on rat blood-peritoneal barrier permeability.
    Avasthi PS
    J Lab Clin Med; 1979 Aug; 94(2):295-302. PubMed ID: 458247
    [No Abstract]   [Full Text] [Related]  

  • 58. Renal tubular effects of the aminonucleoside of puromycin.
    Nagle RB; Bulger RE; Striker GE; Benditt EP
    Lab Invest; 1972 May; 26(5):558-65. PubMed ID: 5021316
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of the potent nephrotogenic aminonucleoside of puromycin on mitochondrial mechanochemistry.
    Maeda J; Bartlett P
    Biochem Pharmacol; 1967 May; 16(5):761-8. PubMed ID: 6036727
    [No Abstract]   [Full Text] [Related]  

  • 60. Differential cytotoxicity between transformed and normal human cells with combinations of aminonucleoside and hydroxyurea.
    Bradley MO; Kohn KW; Sharkey NA; Ewig RA
    Cancer Res; 1977 Jul; 37(7 Pt 1):2126-31. PubMed ID: 861939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.